Footnotes
ID | footnote |
f1 |
stock option to buy 302,847 shares was granted pursuant to the 2017 omnibus incentive plan and vests in five equal annual installments beginning on march 15, 2019. |
f2 |
issuer and fidelity national financial, inc. ("fnf") entered into an agreement and plan of merger dated effective february 7, 2020 (the "merger agreement"), pursuant to which fnf acquired issuer on june 1, 2020 (the "merger"). the unexercised portion of this option was converted in the merger into an option to purchase shares of fnf common stock, all in accordance with the merger agreement. |
f3 |
stock option to buy 302,847 shares was granted pursuant to the 2017 omnibus incentive plan and becomes exercisable, if at all, in five equal installments upon the later of (a) the average daily closing price of the issuer's ordinary shares during any 20 consecutive trading days meeting or exceeding five specified price hurdles of $11, $12.75, $14.75, $17 and $20, respectively, and (b) the end of five one year periods ending march 15, 2019, 2020, 2021, 2022 and 2023, respectively. |
f4 |
stock option to buy 76,685 shares was granted pursuant to the 2017 omnibus incentive plan and becomes exercisable, if at all, in five equal annual installments if the average daily closing price of the issuer's ordinary shares for 20 consecutive trading days meets or exceeds specified annual price hurdles of $12 for the one year period ending march 15, 2019, $14.50 for the one year period ending march 15, 2020, $17 for the one year period ending march 15, 2021, $21 for the one year period ending march 15, 2022 and $25 for the one year period ending march 15, 2023, respectively. |
f5 |
stock option to buy 38,891 shares was granted pursuant to the 2017 omnibus incentive plan and vests in four equal annual installments beginning on march 15, 2020. |
f6 |
stock option to buy 38,890 shares was granted pursuant to the 2017 omnibus incentive plan and becomes exercisable, if at all, in four equal installments upon the later of (a) the average daily closing price of the issuer's ordinary shares during any 20 consecutive trading days meeting or exceeding four specified price hurdles of $12.75, $14.75, $17 and $20, respectively, or (b) the end of four one year periods ending march 15, 2020, 2021, 2022 and 2023, respectively. |
f7 |
stock option to buy 38,891 shares was granted pursuant to the 2017 omnibus incentive plan and becomes exercisable, if at all, in three equal annual installments if the issuer's return on equity meets or exceeds specified annual hurdles of 15.50% for the one year period ending december 31, 2020, 15.75% for the one year period ending december 31, 2021, and 16.00% for the one year period ending december 31, 2022. |